The Up to Speed blog provides quick updates on things relevant to RCIGM’s core work: clinical genomic services, lab tests, rWGS reimbursement, and more.
Inozyme is seeking patients with disease-causing variants in the ENPP1 and/or ABCC6 genes for possible participation in a clinical trial.
Earlier this summer, Florida and Arizona started offering Medicaid coverage for rapid whole genome sequencing. Find out more about the latest policies.
Rady Children’s Institute for Genomic Medicine is excited to announce that the current version of our rWGS/urWGS test is now validated to include identification of repeat expansions in the PHOX2B gene, associated with Congenital Central Hypoventilation Syndrome (CCHS), and in the DMPK gene, associated with Myotonic Dystrophy Type 1 (DM1).
For the first time in more than 80 years, San Diego County is expecting a tropical storm to arrive. RCIGM is prepared with back up devices and resources to support any possible outages and downtimes to the best of our ability.
Here at Rady Children’s Institute for Genomic Medicine®, we’re known for our rapid turnaround on tests. Our aim with this blog is to provide you with quick, speedy updates on things relevant to our core work: clinical genomic services, lab tests, rWGS reimbursement, and more. Stay tuned for more.
© 2024 Rady Children's Institute for Genomic Medicine.
